Where does Sartorius make its money?
In addition to biomanufacturing equipment and consumables, Sartorius offers a wide range of products for general lab use, such as scales, pipettes, and filtration equipment. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (40% of 2020 sales), the Americas (35%), and Asia-Pacific (25%).
What is the business model of Sartorius?
Sartorius AG is the leading provider of biopharmaceutical fermentation and fluid management. In 2020, the bioprocess division contributed 76% to total revenue and the lab division the remaining 24%. The bioprocess division is traded as a separate company, Sartorius Stedim Biotech.
What's new at Sartorius?
Sartorius will open a new 130,000-square-foot (12,000-square-meter) state-of-the art plant in Ann Arbor in late 2023. The life science group Sartorius officially opened its new, significantly expanded Application and Service Hub in Zhangjiang Science City in Shanghai, China.
What does Sartorius AG do?
Sartorius AG specializes in the design, manufacturing and marketing of medical equipments for the pharmaceutical, chemical and food processing industries. The group also develops mechatronic instruments for industrial and laboratory applications. Net sales break down by family of products as follows: - biotechnological equipments.
Is SARTF stock a buy right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft in the last twelve months. There are currentl...
How has Sartorius Aktiengesellschaft's stock performed in 2022?
Sartorius Aktiengesellschaft's stock was trading at $530.76 at the start of the year. Since then, SARTF stock has decreased by 24.0% and is now tra...
How were Sartorius Aktiengesellschaft's earnings last quarter?
Sartorius Aktiengesellschaft (OTCMKTS:SARTF) issued its quarterly earnings data on Thursday, April, 21st. The company reported $2.74 earnings per s...
Who are Sartorius Aktiengesellschaft's key executives?
Sartorius Aktiengesellschaft's management team includes the following people: Dr. Joachim Kreuzburg , Chairman of Exec. Board & CEO (Age 57, Pay...
Who are some of Sartorius Aktiengesellschaft's key competitors?
Some companies that are related to Sartorius Aktiengesellschaft include Straumann (SAUHF) , DENTSPLY SIRONA (XRAY) , Envista (NVST) , SmileDire...
What is Sartorius Aktiengesellschaft's stock symbol?
Sartorius Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "SARTF."
How do I buy shares of Sartorius Aktiengesellschaft?
Shares of SARTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is Sartorius Aktiengesellschaft's stock price today?
One share of SARTF stock can currently be purchased for approximately $403.13.
How much money does Sartorius Aktiengesellschaft make?
Sartorius Aktiengesellschaft (OTCMKTS:SARTF) has a market capitalization of $13.80 billion and generates $4.08 billion in revenue each year. The co...
Is Sartorius growing?
Is Sartorius forecasting for 2021?
The life science group Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the year with significant double-digit growth rates in sales revenue, order intake1 and earnings, reporting further gains in both divisions and across all geographies.
How much does Sartorius make?
Sartorius provides preliminary first-half financial key figures and raises forecast for 2021. Sartorius announces today that it expects strong first–half performance and raises its forecast for the full year of 2021.
Is Sartorius Aktiengesellschaft a hold?
Sartorius Aktiengesellschaft has a market capitalization of $19.57 billion and generates $2.67 billion in revenue each year. The company earns $258.47 million in net income (profit) each year or $4.99 on an earnings per share basis.
